Granules India Limited

NSE GRANULES.NS

Granules India Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2024: USD 918.84 K

Granules India Limited Net Cash Used Provided By Financing Activities is USD 918.84 K for the year ending March 31, 2024, a 101.45% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Granules India Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2023 was USD -63.20 M, a -352.59% change year over year.
Granules India Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2022 was USD 25.02 M, a 161.21% change year over year.
Granules India Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2021 was USD -40.88 M, a -44.72% change year over year.
Granules India Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2020 was USD -28.25 M, a -1,025.87% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

NSE: GRANULES.NS

Granules India Limited

CEO	Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D.
IPO Date	June 20, 2005
Location	India
Headquarters	My Home Hub
Employees	4,057
Sector	Health Care
Industries Pharmaceuticals

Description

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Key trends

Past 5 years